Literature DB >> 11320446

Brain imaging of attentional networks in normal and pathological states.

D Fernandez-Duque1, M I Posner.   

Abstract

The ability to image the human brain has provided a new perspective for neuropsychologists in their efforts to understand, diagnose, and treat insults to the human brain that might occur as the result of stroke, tumor, traumatic injury, degenerative disease, or errors in development. These new findings are the major theme of this special issue. In our article, we consider brain networks that carry out the functions of attention. We outline several such networks that have been studied in normal and pathological states. These include networks for orienting to sensory stimuli, for maintaining the alert state, and for orchestrating volitional control. There is evidence that these networks have a certain degree of anatomical and functional independence, but that they also interact in many practical situations. Damage to each of these networks, irrespective of the source, produces distinctive neuropsychological deficits. We consider the links between the etiology of the injury and changes in cognition and behavior and examine the role of brain imaging in the study of rehabilitation.

Entities:  

Mesh:

Year:  2001        PMID: 11320446     DOI: 10.1076/jcen.23.1.74.1217

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  27 in total

1.  A new semantic vigilance task: vigilance decrement, workload, and sensitivity to dual-task costs.

Authors:  Samantha L Epling; Paul N Russell; William S Helton
Journal:  Exp Brain Res       Date:  2015-09-24       Impact factor: 1.972

2.  Latent profiles of executive functioning in healthy young adults: evidence of individual differences in hemispheric asymmetry.

Authors:  Holly K Rau; Yana Suchy; Jonathan E Butner; Paula G Williams
Journal:  Psychol Res       Date:  2015-09-26

3.  Orienting and alerting: effect of 24 h of prolonged wakefulness.

Authors:  Maria Casagrande; Diana Martella; Enrico Di Pace; Fabio Pirri; Francesco Guadalupi
Journal:  Exp Brain Res       Date:  2005-11-25       Impact factor: 1.972

4.  Management of attentional resources in within-modal and cross-modal divided attention tasks: an fMRI study.

Authors:  Rene Vohn; Bruno Fimm; Jochen Weber; Ralph Schnitker; Armin Thron; Will Spijkers; Klaus Willmes; Walter Sturm
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

5.  The time course of alerting effect over orienting in the attention network test.

Authors:  Luis J Fuentes; Guillermo Campoy
Journal:  Exp Brain Res       Date:  2007-11-08       Impact factor: 1.972

6.  Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition.

Authors:  Rachel V Kozink; Avery M Lutz; Jed E Rose; Brett Froeliger; F Joseph McClernon
Journal:  Addict Biol       Date:  2010-10       Impact factor: 4.280

7.  Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study.

Authors:  Barbara Drueke; Julia Baetz; Maren Boecker; Olaf Moeller; Christoph Hiemke; Gerd Gründer; Siegfried Gauggel
Journal:  Psychopharmacology (Berl)       Date:  2009-09-16       Impact factor: 4.530

8.  Information processing and magnetic resonance imaging indices of brain pathology in multiple sclerosis.

Authors:  Antonina Omisade; John D Fisk; Raymond M Klein; Matthias Schmidt; Sultan Darvesh; Virender Bhan
Journal:  Int J MS Care       Date:  2012

9.  Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder.

Authors:  K M Dorval; K G Wigg; J Crosbie; R Tannock; J L Kennedy; A Ickowicz; T Pathare; M Malone; R Schachar; C L Barr
Journal:  Genes Brain Behav       Date:  2006-09-08       Impact factor: 3.449

10.  Impaired cognition and attention in adults: pharmacological management strategies.

Authors:  Hervé Allain; Yvette Akwa; Lucette Lacomblez; Alain Lieury; Danièle Bentué-Ferrer
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.